Reviva Research Development from 2010 to 2026
| RVPH Stock | USD 0.29 0 0.90% |
Research Development | First Reported 2019-03-31 | Previous Quarter 3.7 M | Current Value 2.1 M | Quarterly Volatility 3 M |
Check Reviva Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Reviva Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 37.2 M, Interest Expense of 15.8 K or Selling General Administrative of 4.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 69.77. Reviva financial statements analysis is a perfect complement when working with Reviva Pharmaceuticals Valuation or Volatility modules.
Reviva | Research Development | Build AI portfolio with Reviva Stock |
The Research Development trend for Reviva Pharmaceuticals Holdings offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Reviva Pharmaceuticals is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Reviva Pharmaceuticals' Research Development Growth Pattern
Below is the plot of the Research Development of Reviva Pharmaceuticals Holdings over the last few years. It is Reviva Pharmaceuticals' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Reviva Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Reviva Research Development Regression Statistics
| Arithmetic Mean | 8,302,258 | |
| Geometric Mean | 2,324,989 | |
| Coefficient Of Variation | 140.92 | |
| Mean Deviation | 10,090,340 | |
| Median | 946,301 | |
| Standard Deviation | 11,699,412 | |
| Sample Variance | 136.9T | |
| Range | 31.2M | |
| R-Value | 0.80 | |
| Mean Square Error | 52.3T | |
| R-Squared | 0.64 | |
| Significance | 0.0001 | |
| Slope | 1,856,123 | |
| Total Sum of Squares | 2190T |
Reviva Research Development History
About Reviva Pharmaceuticals Financial Statements
Investors use fundamental indicators, such as Reviva Pharmaceuticals' Research Development, to determine how well the company is positioned to perform in the future. Although Reviva Pharmaceuticals' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Research Development | 26.3 M | 27.7 M |
Currently Active Assets on Macroaxis
When determining whether Reviva Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Reviva Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Reviva Pharmaceuticals Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Reviva Pharmaceuticals Holdings Stock:Check out the analysis of Reviva Pharmaceuticals Correlation against competitors. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is there potential for Biotechnology market expansion? Will Reviva introduce new products? Factors like these will boost the valuation of Reviva Pharmaceuticals. Anticipated expansion of Reviva directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Reviva Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Reviva Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Reviva Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.